Maxim Group Upgrades Co-Diagnostics (CODX) to Buy
Tweet
Share
E-mailGet Alerts CODX Hot Sheet
Price: $1.16 +1.75%
Rating Summary:
1 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 14 | New: 17
Rating Summary:
1 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 14 | New: 17
Join SI Premium – FREE
Maxim Group analyst Jason McCarthy upgraded Co-Diagnostics (NASDAQ: CODX) from Hold to Buy.
For an analyst ratings summary and ratings history on Co-Diagnostics click here. For more ratings news on Co-Diagnostics click here.
Shares of Co-Diagnostics closed at $18.85 yesterday.
You May Also Be Interested In
- Cleveland Research Upgrades Dynatrace Inc. (DT) to Buy, 'optimism underlying fundamentals are likely to support upside'
- Northcoast Research Upgrades Badger Meter (BMI) to Neutral
- HSBC Upgrades Topdanmark (TOP:DC) (TPDKY) to Hold
Create E-mail Alert Related Categories
UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
